Armed car-macrophage compositions and methods of use therof
TW202641483APending Publication Date: 2026-10-16RENABIO THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW115101507
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-01-14
- Filing Date
- 2026-01-14
- Publication Date
- 2026-10-16
Smart Images

Figure TWG2TA001080948_001 
Figure TWG2TA001080948_002 
Figure TWG2TA001080948_003
Abstract
A nanoparticle for selective transfection of M2 macrophages, the nanoparticle including a lipid phase and a core that contains one or more nucleic acids. The nanoparticle selectively delivers the one or more nucleic acids to M2 macrophages in vitro and in vivo. Also provided is a therapeutic composition that contains a plurality of the nanoparticle described above and a pharmaceutically acceptable excipient. Further provided are methods for selective transfection of M2 macrophages, for converting M2 macrophages into M1 macrophages, and for treating a cancerous tumor. The methods are carried out by contacting M2 macrophages with a composition that includes a plurality of the nanoparticle mentioned above.
Need to check novelty before this filing date? Find Prior Art
